“Hypo awareness week is taking on extra significance this year. With the unavailability of GLP-1 receptor analogues and a greater reliance on insulin and sulfonylurea use, the risk of having a low blood glucose has increased. It’s up to all of us looking after people with diabetes on these agents to make sure they are educated about the risks of hypoglycaemia and what they can do to prevent them and treat them when they occur.”